Market By Test Types, Technology, Display Device, End-users And Geography | Forecasts 2019-2027
The detailed research by Triton represents that the cardiovascular diseases market is expected to display an upward trend and is growing at a CAGR of 5.31% in terms of revenue from 2019 to 2027.
Cardiovascular diseases involve the sickness of heart or blood vessels. Cardiovascular disease comprises of coronary artery diseases (CAD) such as myocardial infarction also known as a heart attack and angina. Other CVDs include stroke, rheumatic heart, heart failure, hypertensive heart disease, disease, heart arrhythmia, cardiomyopathy, congenital heart disease, venous thrombosis carditis, valvar heart disease, thromboembolic disease, aortic aneurysms, and peripheral artery disease.
The primary procedures differ depending on the disease. For example; Atherosclerosis is a condition, which develops due to building up of a substance called plaque in the walls of the arteries. This condition narrows the arteries, making it harder for blood to flow through. If a blood clot forms then it can stop the flow of the blood, resulting in a heart attack or stroke.
Cardiovascular diseases can be treated or prevented through various medications. The drugs used for the treatment of cardiovascular diseases either enhance the pumping capacity of the heart or increase the supply of oxygen to the heart. The major drugs prescribed for the treatment of cardiovascular diseases consists of heparin, Coumadin (warfarin), Zebeta (bisoprolol), Sectral (acebutolol), Lopressor, Toprol XL (metoprolol), Lotrel (amlodipine), Norvasc, Sular (nisoldipine) and Vascor (bepridil).
For addressing the unmet needs regarding the development of cardiovascular diseases drugs, researchers are focusing on the development of cell-based therapies. For example, Dabigatran (Pradaxa; Boehringer Ingelheim, USA) is a direct thrombin inhibitor and Darapladib (GlaxoSmithKline Inc., UK), is a lipoprotein-associated phospholipase A2 inhibitor. In addition, apart from ingestion of drugs through conventional mode, i.e., oral and parenteral, various developed devices are also being introduced in the market that enables drug delivery by mode of balloons, drug-eluting stents, and drug-eluting vascular grafts.
The Triton report on cardiovascular ultrasound market discusses in detail about the key insights, value chain outlook, market outlook, key buying outlook, Porter’s five force analysis, and regulatory outlook.
The key drivers like technology advancement, rising healthcare expenditure, rise in the usages of minimally invasive procedures and surge in cardiovascular diseases are escalating the growth of the market across the globe. The factors such as increasing adoption of alternative technologies, weak reimbursement policy and the high cost of surgeries are affecting the market growth negatively.
The prime factors such as rapidly rising demand for mobile-based ultrasonic devices and upsurge in the research and development are anticipated to leverage the market growth between the projected years. However, Challenges such as interventional cardiology device complications, stringent government regulations and high cost associated with coronary stents and cardiac catheter-based treatment are hindering the development of the market significantly.
The key geographies studied in the cardiovascular ultrasound market are:
o North America: the United States and Canada
o Europe: United Kingdom, Germany, France, Italy, Benelux, Russia and Rest of Europe
o Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia Pacific
o Latin America: Brazil, Mexico, and Argentina
o The Middle East and Africa: Israel, Iran, Saudi Arabia, South Africa and Rest of the Middle East and Africa
The cardiovascular ultrasound market is segmented into:
• By test types:
o Transthoracic Echocardiogram
o Transesophageal Echocardiogram
o Stress Echocardiogram
o Other Echocardiogram
• By technology:
o 2D Ultrasound
o 3D & 4D Ultrasound
o Doppler Imaging
• By display device:
o Color display
o Black and white display
• By end-user:
o Hospitals and cardiology centers
o Home and ambulatory care settings
o Other end users
The leading companies in the cardiovascular ultrasound market are Samsung Electronics Co. Ltd., GE Healthcare Inc., Unetixs Vascular Inc., Hitachi Medical Corporation, Atricure Inc., Toshiba Medical Systems Corporation, Esaote S.P.A, Fujifilm Holdings Corporation, Boston Scientific Corporation, and Chison Medical Imaging Co. Ltd.
The strategic analysis for each of these companies in the cardiovascular ultrasound market is covered in detail. The company market share helps to dive into the information about the key market players and their hold on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Test Types, Technolo ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT1. CARDIOVASCULAR
ULTRASOUND MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTERS
FIVE FORCES OUTLOOK
2.1.1. INTENSITY
OF COMPETITIVE RIVALRY
2.1.2. THREATS
OF NEW ENTRANTS
2.1.3. THREAT
OF SUBSTITUTE PRODUCTS
2.1.4. BARGAINING
POWER OF BUYER
2.1.5. BARGAINING
POWER OF SUPPLIER
2.2. KEY
INSIGHTS
2.3. VALUE
CHAIN OUTLOOK
2.4. MARKET
OUTLOOK
2.5. KEY
BUYING OUTLOOK
2.6. REGULATORY
OUTLOOK
2.7. MARKET
DRIVERS
2.7.1. ADVANCEMENT
IN TECHNOLOGY
2.7.2. RISING
HEALTHCARE EXPENDITURE
2.7.3. RISE
IN THE USAGES OF MINIMALLY INVASIVE PROCEDURES
2.7.4. SURGE
IN CARDIOVASCULAR DISEASES
2.8. MARKET
RESTRAINTS
2.8.1. INCREASING
ADOPTION OF ALTERNATIVE TECHNOLOGIES
2.8.2. WEAK
REIMBURSEMENT POLICY
2.8.3. HIGH
COST OF SURGERIES
2.9. MARKET
OPPORTUNITIES
2.9.1. RAPID
INCREASE IN THE DEMAND OF MOBILE-BASED ULTRASOUND DEVICES
2.9.2. UPSURGE
IN THE RESEARCH AND DEVELOPMENT
2.10.
MARKET CHALLENGES
2.10.1.
INTERVENTIONAL CARDIOLOGY
DEVICES COMPLICATIONS
2.10.2.
STRINGENT GOVERNMENT
REGULATIONS
2.10.3.
HIGH COST ASSOCIATED WITH
CORONARY STENTS AND CARDIAC CATHETER-BASED TREATMENT
3. CARDIOVASCULAR
ULTRASOUND INDUSTRY OUTLOOK – BY TEST TYPES
3.1. TRANSTHORACIC
ECHOCARDIOGRAM
3.2. TRANSESOPHAGEAL
ECHOCARDIOGRAM
3.3. STRESS
ECHOCARDIOGRAM
3.4. OTHER
ECHOCARDIOGRAM
4. CARDIOVASCULAR
ULTRASOUND INDUSTRY OUTLOOK – BY TECHNOLOGY
4.1. 2D
ULTRASOUND
4.2. 3D
& 4D ULTRASOUND
4.3. DOPPLER
IMAGING
5. CARDIOVASCULAR
ULTRASOUND INDUSTRY OUTLOOK – BY DISPLAY DEVICE
5.1. COLOR DISPLAY
5.2. BLACK
& WHITE DISPLAY
6. CARDIOVASCULAR
ULTRASOUND INDUSTRY OUTLOOK – BY END-USER
6.1. HOSPITAL
& CARDIOLOGY CENTERS
6.2. HOME
& AMBULATORY CARE SETTINGS
6.3. OTHER
END USERS
7. CARDIOVASCULAR
ULTRASOUND INDUSTRY – REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY TEST TYPES
7.1.2. MARKET
BY TECHNOLOGIES
7.1.3. MARKET
BY DISPLAY DEVICES
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. THE
UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY TEST TYPES
7.2.2. MARKET
BY TECHNOLOGIES
7.2.3. MARKET
BY DISPLAY DEVICES
7.2.4. MARKET
BY END-USER
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. THE
UK
7.2.5.3. FRANCE
7.2.5.4. RUSSIA
7.2.5.5. BENELUX
7.2.5.6. ITALY
7.2.5.7. REST
OF EUROPE
7.3. ASIA
PACIFIC
7.3.1. MARKET
BY TEST TYPES
7.3.2. MARKET
BY TECHNOLOGIES
7.3.3. MARKET
BY DISPLAY DEVICES
7.3.4. MARKET
BY END-USER
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. JAPAN
7.3.5.2. CHINA
7.3.5.3. SOUTH
KOREA
7.3.5.4. INDIA
7.3.5.5. AUSTRALIA
& NEW ZEALAND
7.3.5.6. ASEAN
COUNTRIES
7.3.5.7. REST
OF APAC
7.4. REST
OF WORLD
7.4.1. MARKET
BY TEST TYPES
7.4.2. MARKET
BY TECHNOLOGIES
7.4.3. MARKET
BY DISPLAY DEVICES
7.4.4. MARKET
BY END-USER
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. LATIN
AMERICA
7.4.5.1.1.
MEXICO
7.4.5.1.2.
BRAZIL
7.4.5.1.3.
ARGENTINA
7.4.5.2. MIDDLE
EAST & AFRICA
7.4.5.2.1.
ISRAEL
7.4.5.2.2.
IRAN
7.4.5.2.3.
SAUDI ARABIA
7.4.5.2.4.
SOUTH AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. COMPETITIVE
OUTLOOK
8.1.1. MARKET
SHARE OUTLOOK
8.1.2. TOP
COMPANIES
8.2. SAMSUNG
ELECTRONICS CO. LTD.
8.3. UNETIXS
VASCULAR INC. (ACQUIRED BY OPTO CIRCUITS)
8.4. ATRICURE
INC
8.5. ESAOTE
S.P.A
8.6. BOSTON
SCIENTIFIC CORPORATION
8.7. GE
HEALTHCARE INC.
8.8. HITACHI
MEDICAL CORPORATION
8.9. TOSHIBA
MEDICAL SYSTEMS CORPORATION (ACQUIRED BY CANON INC.)
8.10.
FUJIFILM HOLDINGS CORPORATION
8.11.
CHISON
MEDICAL IMAGING CO. LTD.
8.12.
MINDRAY MEDICAL INTERNATIONAL
LIMITED
8.13.
PHILIPS HEALTHCARE
8.14.
ABBOTT VASCULAR INC.
8.15.
STRYKER CORPORATION
8.16.
ULTRASOUND TECHNOLOGIES LTD.
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE
1 GLOBAL CARDIOVASCULAR ULTRASOUND
SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)
TABLE
2 TYPES OF SURGERY AND PRICE IN THE
US
TABLE
3 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE
4 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN TRANSTHORACIC ECHOCARDIOGRAM BY REGION 2019-2027 ($ MILLION)
TABLE
5 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM BY REGION 2019-2027 ($ MILLION)
TABLE
6 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN STRESS ECHOCARDIOGRAM BY REGION 2019-2027 ($ MILLION)
TABLE
7 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN OTHER ECHOCARDIOGRAM BY REGION 2019-2027 ($ MILLION)
TABLE
8 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
9 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN 2D ULTRASOUND 2019-2027 ($ MILLION)
TABLE
10 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN 3D & 4D ULTRASOUND 2019-2027 ($ MILLION)
TABLE
11 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN DOPPLER IMAGING 2019-2027 ($ MILLION)
TABLE
12 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
13 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN COLOUR DISPLAY BY REGION 2019-2027 ($ MILLION)
TABLE
14 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN BLACK & WHITE DISPLAY BY REGION 2019-2027 ($ MILLION)
TABLE
15 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
16 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2019-2027 ($ MILLION)
TABLE
17 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN HOME & AMBULATORY CARE SETTINGS 2019-2027 ($ MILLION)
TABLE
18 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN OTHER END USERS 2019-2027 ($ MILLION)
TABLE
19 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET BY REGION 2019-2027 ($ MILLION)
TABLE
20 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE
21 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE
22 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET BY DISPLAY DEVICES 2019-2027 ($ MILLION)
TABLE
23 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
24 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
25 THE UNITED STATES CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
26 THE UNITED STATES CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
27 THE UNITED STATES CARDIOVASCULAR
ULTRASOUND MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
28 THE UNITED STATES CARDIOVASCULAR
ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
29 CANADA CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
30 CANADA CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
31 CANADA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
32 CANADA CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
33 EUROPE CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE
34 EUROPE CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE
35 EUROPE CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICES 2019-2027 ($ MILLION)
TABLE
36 EUROPE CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
37 EUROPE CARDIOVASCULAR ULTRASOUND
MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
38 GERMANY CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
39 GERMANY CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
40 GERMANY CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
41 GERMANY CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
42 THE UK CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
43 THE UK CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
44 THE UK CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
45 THE UK CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
46 FRANCE CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
47 FRANCE CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
48 FRANCE CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
49 FRANCE CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
50 RUSSIA CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
51 RUSSIA CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
52 RUSSIA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
53 RUSSIA CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
54 BENELUX
CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
55 BENELUX
CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
56 BENELUX
CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
57 BENELUX
CARDIOVASCULAR ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
58 ITALY CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
59 ITALY CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
60 ITALY CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
61 ITALY CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
62 REST OF EUROPE CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
63 REST OF EUROPE CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
64 REST OF EUROPE CARDIOVASCULAR
ULTRASOUND MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
65 REST OF EUROPE CARDIOVASCULAR
ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
66 ASIA PACIFIC CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE
67 ASIA PACIFIC CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE
68 ASIA PACIFIC CARDIOVASCULAR
ULTRASOUND MARKET BY DISPLAY DEVICES 2019-2027 ($ MILLION)
TABLE
69 ASIA PACIFIC CARDIOVASCULAR
ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
70 ASIA PACIFIC CARDIOVASCULAR
ULTRASOUND MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
71 JAPAN CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
72 JAPAN CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
73 JAPAN CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
74 JAPAN CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
75 CHINA CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
76 CHINA CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
77 CHINA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
78 CHINA CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
79 SOUTH KOREA CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
80 SOUTH KOREA CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
81 SOUTH KOREA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
82 SOUTH KOREA CARDIOVASCULAR
ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
83 INDIA CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
84 INDIA CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
85 INDIA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
86 INDIA CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
87 AUSTRALIA & NEW ZEALAND
CARDIOVASCULAR ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
88 AUSTRALIA & NEW ZEALAND
CARDIOVASCULAR ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
89 AUSTRALIA & NEW ZEALAND
CARDIOVASCULAR ULTRASOUND MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
90 AUSTRALIA & NEW ZEALAND
CARDIOVASCULAR ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
91 REST OF APAC CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
92 REST OF APAC CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
93 REST OF APAC CARDIOVASCULAR
ULTRASOUND MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
94 REST OF APAC CARDIOVASCULAR
ULTRASOUND MARKET BY END USER 2019-2027 ($ MILLION)
TABLE
95 REST OF WORLD CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE
96 REST OF WORLD CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE
97 REST OF WORLD CARDIOVASCULAR
ULTRASOUND MARKET BY DISPLAY DEVICES 2019-2027 ($ MILLION)
TABLE
98 REST OF WORLD CARDIOVASCULAR
ULTRASOUND MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
99 REST OF WORLD CARDIOVASCULAR
ULTRASOUND MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE
100 LATIN AMERICA CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
TABLE
101 MEXICO CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
102 MEXICO CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
103 MEXICO CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
104 MEXICO CARDIOVASCULAR ULTRASOUND MARKET
BY END-USER 2019-2027 ($ MILLION)
TABLE
105 BRAZIL CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
106 BRAZIL CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
107 BRAZIL CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
108 BRAZIL CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
109 ARGENTINA CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
110 ARGENTINA CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
111 ARGENTINA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
112 ARGENTINA CARDIOVASCULAR ULTRASOUND
MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
113 IRAN CARDIOVASCULAR ULTRASOUND
MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
114 IRAN CARDIOVASCULAR ULTRASOUND
MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
115 IRAN CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
116 IRAN CARDIOVASCULAR ULTRASOUND
MARKET BY END USER 2019-2027 ($ MILLION)
TABLE
117 SAUDI ARABIA CARDIOVASCULAR
ULTRASOUND MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE
118 SAUDI ARABIA CARDIOVASCULAR
ULTRASOUND MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
119 SAUDI ARABIA CARDIOVASCULAR ULTRASOUND
MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE
120 SAUDI ARABIA CARDIOVASCULAR
ULTRASOUND MARKET BY END USER 2019-2027 ($ MILLION)
FIGURE
1 GLOBAL CARDIOVASCULAR ULTRASOUND
SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE
2 REGULATORY OUTLOOKS IN
CARDIOVASCULAR ULTRASOUND MARKET
FIGURE
3 RATE OF CARDIAC DISEASES IN AMERICA
2017 (%)
FIGURE
4 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN TRANSTHORACIC ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE
5 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE
6 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN STRESS ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE
7 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN OTHER ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE
8 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN 2D ULTRASOUND 2019-2027 ($ MILLION)
FIGURE
9 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN 3D & 4D ULTRASOUND 2019-2027 ($ MILLION)
FIGURE
10 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN DOPPLER IMAGING 2019-2027 ($ MILLION)
FIGURE
11 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN COLOR DISPLAY 2019-2027 ($ MILLION)
FIGURE
12 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN BLACK & WHITE DISPLAY 2019-2027 ($ MILLION)
FIGURE
13 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2019-2027 ($ MILLION)
FIGURE
14 GLOBAL CARDIOVASCULAR ULTRASOUND MARKET
IN HOME & AMBULATORY CARE SETTINGS 2019-2027 ($ MILLION)
FIGURE
15 GLOBAL CARDIOVASCULAR ULTRASOUND
MARKET IN OTHER END-USER 2019-2027 ($ MILLION)
FIGURE
16 NORTH AMERICA CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
17 THE UNITED STATES CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
18 CANADA CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
19 EUROPE CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
20 GERMANY CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
21 THE UK CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
22 FRANCE CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
23 RUSSIA CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
24 BENELUX
CARDIOVASCULAR ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
25 ITALY CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
26 REST OF EUROPE CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
27 ASIA PACIFIC CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
28 JAPAN CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
29 CHINA CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
30 SOUTH KOREA CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
31 INDIA CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
32 AUSTRALIA & NEW ZEALAND
CARDIOVASCULAR ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
33 ASEAN COUNTRIES CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
34 REST OF APAC CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
35 REST OF WORLD CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
36 LATIN AMERICA CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
37 MEXICO CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
38 BRAZIL CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
39 ARGENTINA CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
40 MIDDLE EAST & AFRICA
CARDIOVASCULAR ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
41 MIDDLE EAST & AFRICA
CARDIOVASCULAR ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
42 ISRAEL CARDIOVASCULAR ULTRASOUND
MARKET 2019-2027 ($ MILLION)
FIGURE
43 IRAN CARDIOVASCULAR ULTRASOUND MARKET
2019-2027 ($ MILLION)
FIGURE
44 SAUDI ARABIA CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
45 SOUTH AFRICA CARDIOVASCULAR
ULTRASOUND MARKET 2019-2027 ($ MILLION)
FIGURE
46 CARDIOVASCULAR ULTRASOUND SYSTEM
MARKET SHARE 2018 (%)